844 filings
Page 3 of 43
8-K
ENVB
Enveric Biosciences Inc
31 Oct 23
Regulation FD Disclosure
8:05am
8-K
ENVB
Enveric Biosciences Inc
20 Oct 23
Enveric Biosciences to Present at the Centurion One 5th Global Summit
8:05am
8-K
ENVB
Enveric Biosciences Inc
18 Oct 23
Key preclinical milestone designed to establish safety profile and maximum tolerated dose for anticipated clinical trial of EB-373
8:05am
8-K
ENVB
Enveric Biosciences Inc
11 Oct 23
Enveric Biosciences Announces Two Poster Presentations at the 6th Neuropsychiatric Drug Development Summit
8:05am
8-K
ENVB
Enveric Biosciences Inc
3 Oct 23
Enveric Biosciences Announces its Psybrary™ Portfolio Now Totals Over 1000 Psychedelic-Inspired Therapeutic Candidates
8:05am
8-K
ENVB
Enveric Biosciences Inc
27 Sep 23
Regulation FD Disclosure
8:05am
8-K
ENVB
Enveric Biosciences Inc
20 Sep 23
Regulation FD Disclosure
8:05am
4
Pasqualone Frank
19 Sep 23
Enveric Biosciences / FRANK PASQUALONE ownership change
5:34pm
ARS
2022 FY
ENVB
Enveric Biosciences Inc
18 Sep 23
Annual report to shareholders
5:00pm
DEFA14A
ENVB
Enveric Biosciences Inc
18 Sep 23
Additional proxy soliciting materials
4:53pm
DEF 14A
ENVB
Enveric Biosciences Inc
Definitive proxy
18 Sep 23
4:50pm
8-K
ENVB
Enveric Biosciences Inc
18 Sep 23
Enveric Biosciences to Present Poster Highlighting EVM301 Series at the International Conference on Molecular Biology and Biochemistry 2023
8:05am
8-K
ENVB
Enveric Biosciences Inc
11 Sep 23
Enveric utilizing AI-backed 3D modeling to identify potential non-hallucinogenic, neuroplastic tryptamine derivative NCEs for its EVM301 Series
8:05am
PRE 14A
ENVB
Enveric Biosciences Inc
Preliminary proxy
7 Sep 23
5:25pm
8-K
ENVB
Enveric Biosciences Inc
5 Sep 23
Enveric Biosciences Announces New U.S. Patent for C4-Carboxylic Acid-Substituted Tryptamine Derivatives
8:05am
424B5
ENVB
Enveric Biosciences Inc
1 Sep 23
Prospectus supplement for primary offering
5:28pm
8-K
ENVB
Enveric Biosciences Inc
1 Sep 23
Entry into a Material Definitive Agreement
5:26pm
8-K
ENVB
Enveric Biosciences Inc
28 Aug 23
Regulation FD Disclosure
5:13pm
8-K
ENVB
Enveric Biosciences Inc
28 Aug 23
Enveric Biosciences Strengthens Intellectual Property Portfolio with New U.S. Patent for Tryptamine-derived Prodrugs
8:00am
8-K
ENVB
Enveric Biosciences Inc
21 Aug 23
Enveric Biosciences Completes Manufacturing of EB-373 to Supply Drug Material for Completion of Preclinical Program
7:55am